Komunikaty PR

By 2030, the electrophysiology market is anticipated to witness robust growth at a CAGR of 14.4%.

2025-08-20  |  12:55:05
PORTLAND, NY, UNITED STATES, August 20, 2025 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global electrophysiology market was estimated at $6.49 billion in 2020 and is expected to hit $22.65 billion by 2030, registering a CAGR of 14.4% from 2021 to 2030.

Drivers, restraints, and opportunities
Rise in prevalence of cardiac arrhythmia, increase in demand for minimally invasive procedures, advancements in technology in the field of electrophysiology, and surge in number of approvals for electrophysiology devices drive the growth of the global electrophysiology market. On the other hand, high cost of electrophysiological devices impedes the growth to some extent. However, increase in number of key players to manufacture advanced electrophysiology devices is expected to create lucrative opportunities in the industry.

Download Report Summary- https://www.alliedmarketresearch.com/request-sample/452

Key Market Drivers:

Rising Prevalence of Cardiovascular Diseases:
The increasing incidence of heart conditions like arrhythmias and atrial fibrillation is a major factor fueling the demand for EP procedures and devices.

Technological Advancements:
Innovations in EP devices, such as 3D mapping systems, catheter ablation systems, and diagnostic tools, are enhancing the effectiveness and safety of treatments, thus boosting market growth.

Minimally Invasive Procedures:
The preference for minimally invasive techniques like catheter ablation, which offer faster recovery times and reduced risks compared to traditional surgery, is contributing to market expansion.

Electrophysiology is defined as the branch of science that deals with the study of electrical pathway associated with heart nervous system.

Electrophysiology devices are designed to measure electric current or voltage change on a wide range of scale from single ion channel protein to organs such as heart. The electrophysiology procedure is used to analyze heart’s electrical system and to manage abnormal heart rhythms.

The EP ablation catheters segment to retain the lion’s share-

On the basis of product, the EP ablation catheters segment held the major share in 2020, garnering more than two-thirds of the global electrophysiology market. The same segment is also expected to grow at the fastest CAGR of 15.20% throughout the forecast period. This is due to surge in number of ablation procedure and advancements in technology to manufacture innovative electrophysiology ablation catheters.

The hospitals & cardiac centers segment to dominate by 2030-

On the basis of end user, the hospitals & cardiac centers segment contributed to the lion’s share in 2020, holding nearly three-fourths of the global electrophysiology market. The same segment is also anticipated to cite the fastest CAGR of 14.90% from 2021 to 2030. This is owing to increase in development of hospital infrastructure, and rise in initiatives taken by government & private organizations to develop hospitals facilities.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/452

North America held the major share in 2020-

By region, the market across North America dominated in 2020, garnering more than two-thirds of the global electrophysiology market. This is due to rise in prevalence of cardiac arrhythmia and increase in number of approvals for electrophysiology devices in the province. Simultaneously, the Asia-Pacific region is expected to cite the fastest CAGR of 15.10% throughout the forecast period. This is attributed to rise in prevalence of atrial fibrillation, advancements in technology in the field of electrophysiology, growth in health care expenditures, and increase in geriatric population in the region.

Key players in the industry:

Biotronik SE & Co. KG
Boston Scientific Corporation
Abbott Laboratories
CardioFocus, Inc.
GE Healthcare
Koninklijke Philips N.V.
Medtronic Plc.
MicroPort Scientific Corporation
Siemens Healthineers AG.
Johnson & Johnson, Inc.

Read More:

body composition analyzers market https://www.alliedmarketresearch.com/body-composition-analyzers-market

bone grafts and substitutes market https://www.alliedmarketresearch.com/bone-graft-substitutes-market

ophthalmology devices market https://www.alliedmarketresearch.com/ophthalmology-devices-market

Contact Details:

David Correa

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022

help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, firmy czy instytucje państwowe.
Ostatnio dodane
komunikaty PR z wybranej przez Ciebie kategorii
EIN Newswire BRAK ZDJĘCIA
2025-08-20 | 14:55:19

Tinplate Packaging Market to Reach USD 3,079 Million by 2035 | AJ Packaging, Ball Corporation, Ardagh Group Lead

Tinplate Packaging MarketTinplate Packaging Market Analysis, By Product Type (Cans, Containers, Lids, and Others), By Application, By Thickness, and Region MD, UNITED STATES, August 20, 2025 /EINPresswire.com/ -- The global tinplate packaging
EIN Newswire BRAK ZDJĘCIA
2025-08-20 | 14:55:19

DisplayRide & Tarsus Partner to Bring the World’s Most Advanced AI Dashcam solution to Canada

Strategic alliance to seize a significant and rapidly growing opportunity in rideshare, driving school & NEMT markets..together with DisplayRide, we’re building a foundation for safer, smarter, and more sustainable gig transportation in
EIN Newswire BRAK ZDJĘCIA
2025-08-20 | 14:55:19

RefillGenie’s Affordable Online Prescription Refills Now Available in 47 States

Leading telehealth platform provides fast, text-based prescription refills in 47 states to prevent dangerous gaps in access to chronic medications. JERSEY CITY, NJ, UNITED STATES, August 20, 2025 /EINPresswire.com/ -- RefillGenie, a telehealth company founded by physicians, provides medication refill services in 47 states across the United States, offering a streamlined solution for patients managing chronic conditions. Millions of Americans face barriers to accessing prescription medications when transitioning between doctors or insurance plans.The service addresses a significant healthcare challenge: medication adherence gaps that can lead to serious complications. According to the company, patients with conditions like diabetes and hypertension may experience life-threatening events, such as strokes and heart attacks, when unable to refill essential medications like blood pressure prescriptions.RefillGenie operates through a text-based platform that eliminates the need for appointments. Patients can refill up to three existing medications through a four-step process: answering health questions, information verification, a brief text consultation with a doctor, and prescription delivery to their pharmacy. The service offers 30-day supplies for $29.99 and 90-day supplies for $59.99."We were tired of seeing patients suffer from strokes and heart attacks simply because they'd run out of their blood pressure medication," said Dr. Stephen Kelly, Founder of RefillGenie. "For that reason, we created this simple, text-based service to ensure anyone can access their life-saving medications when needed."The platform serves patients across Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, West Virginia, Wisconsin, and Wyoming.Patient testimonials highlight the service's efficiency and accessibility. Deep B. shared, "Had a wonderful experience with RefillGenie. Very pleased with their service. Highly recommended. Thank you RefillGenie." Heaven L. noted, "Such a seamless process for being in a pinch! From entering my information to picking up my prescription - all within 12 hours! I am super impressed and will keep this service in mind for the future."The company maintains safety protocols by excluding certain medications from its refill service. These include controlled substances, sedatives, muscle relaxants, lifestyle medications, and medications requiring close monitoring. In cases where bloodwork is needed before refilling, RefillGenie provides lab orders and interpretation at no additional charge.Tina S., another patient, emphasized the service's convenience: "So easy. Everyone is nice and caring. No hassles and very fast. RefillGenie even gave me coupons for discount on prescription! This is easier then Insurance! Thank you! ❤"The service operates 24 hours a day, seven days a week, with a standard turnaround time of 12 hours. Most refills are processed significantly faster than this timeframe. RefillGenie previously expanded its availability to 47 states and Washington D.C. responding to growing demand for accessible healthcare solutions.The company positions itself as a temporary bridge rather than a replacement for primary care physicians. RefillGenie advises patients to re-establish care with local providers who can perform regular physical exams and manage long-term health needs.For patients who have lost health insurance or find themselves between doctors, RefillGenie offers a solution to maintain access to chronic medications. The service particularly benefits individuals dealing with unexpected life events or those traveling who need to maintain their medication regimens.To learn more about how RefillGenie works or to see if your medication qualifies, visit the company website. You can also reach the company by phone at +1 (929)-274-3052. For health tips and updates, visit the company's blog at https://refillgenie.com/news/.

Więcej ważnych informacji

Jedynka Newserii

Jedynka Newserii

Kongres Profesjonalistów Public Relations

Prawo

Kolejne polskie miasta chcą być przyjazne dzieciom. Planują stworzyć najmłodszym dobre warunki do rozwoju

Cztery miasta w Polsce posiadają tytuł Miasta Przyjaznego Dzieciom nadany przez UNICEF Polska. Dziewięć kolejnych miast czeka na certyfikację, a w ostatnich miesiącach do programu zgłosiło się kilka następnych. Na całym świecie inicjatywa została przyjęta już w ponad 4 tys. samorządów, a w Hiszpanii objęła połowę dziecięcej populacji miast. Program UNICEF-u ma na celu zachęcenie włodarzy do traktowania najmłodszych obywateli w sposób podmiotowy, respektowania ich praw i zaproszenia ich do współdecydowania o przyszłości.

Przemysł

W ciągu roku w Polsce ubyło 500 przedsiębiorstw odzieżowo-tekstylnych. Problemem są spadki zamówień z Europy Zachodniej i wzrost kosztów

Wartość rynku odzieżowego w Polsce wynosi 66,9 mld zł, z czego 10 mld zł to wartość krajowej produkcji – wynika z danych PIOT. Od czasu pandemii branża mierzy się z szeregiem wyzwań, wśród których najpoważniejsze to wzrost kosztów pracy i produkcji, przerwane łańcuchy dostaw i spadek zamówień – zarówno w kraju, jak i za granicą, a także wzrost nieuczciwej konkurencji na rynku, czyli głównie importu z Chin. Skala wyzwań sprawia, że w ubiegłym roku z rynku zniknęło 500 firm. Producenci odzieży apelują do rządu o wsparcie.

Handel

D. Obajtek: Orlen powinien być o 30–40 proc. większą spółką. Byłoby to z korzyścią dla konsumentów

Orlen jest największym polskim przedsiębiorstwem. Jego przychody ze sprzedaży w 2024 roku wyniosły blisko 295 mln zł, a rok wcześniej – ponad 372 mln – wynika z raportu Rzeczpospolitej „Lista 500”. W ubiegłorocznym rankingu Fortune 500 uwzględniającym największe korporacje znalazł się na 216. miejscu na świecie i 44. w Europie. Według Daniela Obajtka, europosła PiS-u i byłego prezesa Orlenu, spółka powinna jeszcze urosnąć, tym samym gwarantując konsumentom szereg korzyści, a także przyspieszać inwestycje m.in. w obszarze petrochemii i energetyki zero- oraz niskoemisyjnej.

Partner serwisu

Instytut Monitorowania Mediów

Szkolenia

Akademia Newserii

Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a  także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.